Evaluating the Association of Adverse Events and Patient-Reported Symptoms to Endocrine Therapy Tolerability

J Clin Oncol. 2022 Feb 1;40(4):430-431. doi: 10.1200/JCO.21.02387. Epub 2021 Dec 9.

Authors

N Lynn Henry¹, André Rogatko¹, Patricia A Ganz¹

Affiliation

¹ N. Lynn Henry, MD, PhD, University of Michigan Rogel Cancer Center, Ann Arbor, MI; André Rogatko, PhD, Cedars Sinai Medical Center, Los Angeles, CA; and Patricia A. Ganz, MD, University of California Los Angeles Jonsson Comprehensive Cancer Center, Los Angeles, CA.

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Comment

MeSH terms

Humans
Patient Reported Outcome Measures*

Grants and funding

U01 CA232859/CA/NCI NIH HHS/United States